Rezolute, Inc. (RZLT)
NCM · Common · CUSIP 76200L309
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for RZLT and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
76200L309
Market Cap
Micro Cap
Previous Symbol
RZLTD (changed 11/9/2020)
Business: Rezolute is a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies to improve the lives of patients with metabolic and orphan diseases.

Company Contact

CEO
Nevan Charles Elam
CFO
Nevan Charles Elam
Headquarters
275 Shoreline Drive, Suite 500, Redwood City, CA 94065
Phone
650-206-4507
Investor Relations
Corey Davis, LifeSci Advisors · cdavis@lifesciadvisors.com
General Email
investor-relations@rezolutebio.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »